HER2 and HR characterize the expression of human epidermal growth factor receptor 2 and hormone receptor based on IHC staining of surgical specimens and are widely used biomarkers for invasive breast cancer for treatment selection and response prediction [3]. The gene discussed is NR4A1; the disease is invasive breast carcinoma.